title: Tetanus in Auckland: a preventable disease.
abstract: OBJECTIVE
  To determine the clinical features, management and outcome for patients admitted to hospital with tetanus in Auckland.
  
  
  METHODS
  Medical records of all patients with tetanus admitted to hospitals in Auckland between January 1982 and December 1992 were retrospectively reviewed.
  
  
  RESULTS
  Fifteen patients were admitted to hospital during the study period. All patients were more than 40 years old and no patient had a history of more than one tetanus toxoid immunisation before the injury presumed responsible for tetanus. Failure to consider the diagnosis led to delay in starting appropriate treatment in most patients. Eleven patients required mechanical ventilation. The median duration of hospital stay was 44 days. All patients survived.
  
  
  CONCLUSIONS
  Tetanus is rare in Auckland and almost exclusively affects those born before 1960 when universal childhood immunisation against tetanus was started. The disease causes significant morbidity which could be avoided by increased efforts to ensure that all persons have completed a full course of immunisation. Universal vaccination against tetanus with regular boosters to maintain immunity would also circumvent the problems encountered with postexposure tetanus prophylaxis.
authors.affiliation: Auckland Hospital.
authors.forename: N
authors.initials: N
authors.lastname: Sharma
authors.forename: R
authors.initials: R
authors.lastname: Trubuhovich
authors.forename: M G
authors.initials: MG
authors.lastname: Thomas
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009520:New Zealand; D012189:Retrospective Studies; D013742:Tetanus / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D013743:Tetanus Antitoxin / Q000627:therapeutic use; D013745:Tetanus Toxoid / Q000627:therapeutic use
chemical_list: D007136:Immunoglobulins; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid